Spots Global Cancer Trial Database for Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
Official Title: Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
Study ID: NCT05229575
Conditions
Interventions
Study Description
Brief Summary: This is a dose escalation study involving stage IV breast cancer patients not progressing after 6 months of first line systemic treatment. Potential advantages of stereotactic body radiotherapy (SBRT) in treating breast primary tumor in metastatic breast cancer are: * radio-biological advantage of a short highly effective treatment schedule * possibility of preventing lesions to become symptomatic * possibility of continuing systemic treatment without interruption
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Università Campus Biomedico, Roma, , Italy
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
